Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is scheduled to be issuing its quarterly earnings data on Monday, November 6th. Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) last posted its quarterly earnings data on Friday, August 4th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.02). […]
Related Keywords
, Balyasny Asset Management , Millennium Management , Nasdaq , Renaissance Technologies , Achilles Therapeutics Plc , Virtu Financial , Achilles Therapeutics , Get Free Report , Street Group , Chardan Capital , Therapeutics Plc , Achilles Therapeutics Daily , Nasdaq Achl , Bachl , Medical , Earnings ,
vimarsana.com © 2020. All Rights Reserved.